Literature DB >> 6966518

A rationale for sequential high-dose chemotherapy of leukemia timed to coincide with induced tumor proliferation.

P J Burke, W P Vaughan, J E Karp.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 6966518

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  5 in total

1.  Randomized use of cyclosporin A (CsA) to modulate P-glycoprotein in children with AML in remission: Pediatric Oncology Group Study 9421.

Authors:  David Becton; Gary V Dahl; Yaddanapudi Ravindranath; Myron N Chang; Fred G Behm; Susana C Raimondi; David R Head; Kimo C Stine; Norman J Lacayo; Branimir Ivan Sikic; Robert J Arceci; Howard Weinstein
Journal:  Blood       Date:  2005-10-27       Impact factor: 22.113

Review 2.  Timed sequential therapy for acute myelogenous leukemia: Results of a retrospective study of 301 patients and review of the literature.

Authors:  Kelly J Norsworthy; Amy E DeZern; Hua-Ling Tsai; Wesley A Hand; Ravi Varadhan; Steven D Gore; Ivana Gojo; Keith Pratz; Hetty E Carraway; Margaret Showel; Michael A McDevitt; Douglas Gladstone; Gabriel Ghiaur; Gabrielle Prince; Amy H Seung; Dina Benani; Mark J Levis; Judith E Karp; B Douglas Smith
Journal:  Leuk Res       Date:  2017-08-30       Impact factor: 3.156

3.  Timed sequential chemotherapy following ifosfamide-induced kinetic recruitment in refractory ovarian cancer.

Authors:  R Rosso; A Alama; L Repetto; P F Conte
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

Review 4.  Kinetic resistance to anticancer agents.

Authors:  M T Dimanche-Boitrel; C Garrido; B Chauffert
Journal:  Cytotechnology       Date:  1993       Impact factor: 2.058

5.  Randomized phase II trial of cytosine arabinoside with and without the CHK1 inhibitor MK-8776 in relapsed and refractory acute myeloid leukemia.

Authors:  Jonathan A Webster; Raoul Tibes; Larry Morris; Amanda L Blackford; Mark Litzow; Mrinal Patnaik; Gary L Rosner; Ivana Gojo; Robert Kinders; Lihua Wang; L Austin Doyle; Catherine J Huntoon; Larry M Karnitz; Scott H Kaufmann; Judith E Karp; B Douglas Smith
Journal:  Leuk Res       Date:  2017-09-20       Impact factor: 3.715
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.